ITAT Ahmedabad ruled that a notice under section 148 issued beyond the statutory period is invalid, quashing a ₹115 crore reassessment of a share-trading company. The Tribunal emphasized adherence to ...
The Danish pharmaceutical giant Novo Nordisk finds itself navigating turbulent market conditions. Following a significant clinical setback and sustained share price erosion, the company is now ...
- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention that ...
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced positive results from its pivotal bioequivalence (BE) study evaluating pitolisant ...
The "Epilepsy Therapeutics Market With Impact Analysis of US Tariffs (2025 Edition)" report has been added to ResearchAndMarkets.com's offering.
Aston University's Dr Jonathan Cox and New Zealand Mānuka honey company Comvita have announced a significant milestone in their three-year research collaboration, with the filing of a new patent for a ...
INCHEON, South Korea--(BUSINESS WIRE)--Celltrion, Inc. today announced that the European Commission (EC) has granted marketing authorization for Remsima™ IV (intravenous) liquid formulation, the world ...
Celltrion announced that the European Commission (EC) has granted marketing authorization for Remsima IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab.
Merus N.V., an oncology company developing full-length multispecific antibodies and antibody drug conjugates, and Halozyme Therapeutics Inc., a biopharmaceutical company advancing subcutaneous drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback